CN104041907B - 一种护肝解毒功能饮料及其制备方法 - Google Patents
一种护肝解毒功能饮料及其制备方法 Download PDFInfo
- Publication number
- CN104041907B CN104041907B CN201410314999.7A CN201410314999A CN104041907B CN 104041907 B CN104041907 B CN 104041907B CN 201410314999 A CN201410314999 A CN 201410314999A CN 104041907 B CN104041907 B CN 104041907B
- Authority
- CN
- China
- Prior art keywords
- mass parts
- fructus
- drinks
- liver detoxification
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004185 liver Anatomy 0.000 title claims abstract description 78
- 238000001784 detoxification Methods 0.000 title claims abstract description 61
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 239000003814 drug Substances 0.000 claims abstract description 51
- 210000000582 semen Anatomy 0.000 claims abstract description 37
- 235000013361 beverage Nutrition 0.000 claims abstract description 35
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 claims abstract description 35
- 239000002994 raw material Substances 0.000 claims abstract description 27
- 229940079593 drug Drugs 0.000 claims abstract description 21
- 239000011812 mixed powder Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 230000001954 sterilising effect Effects 0.000 claims description 29
- 239000007788 liquid Substances 0.000 claims description 28
- 239000000203 mixture Substances 0.000 claims description 18
- 238000004659 sterilization and disinfection Methods 0.000 claims description 17
- 238000009835 boiling Methods 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 12
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 12
- 239000008155 medical solution Substances 0.000 claims description 12
- 238000002791 soaking Methods 0.000 claims description 11
- 238000007654 immersion Methods 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 6
- 238000011049 filling Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 239000000796 flavoring agent Substances 0.000 claims 2
- 235000019634 flavors Nutrition 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 57
- 230000001737 promoting effect Effects 0.000 abstract description 21
- 238000004519 manufacturing process Methods 0.000 abstract description 12
- 230000035922 thirst Effects 0.000 abstract description 12
- 239000010839 body fluid Substances 0.000 abstract description 11
- 210000000952 spleen Anatomy 0.000 abstract description 11
- 208000027418 Wounds and injury Diseases 0.000 abstract description 10
- 210000001124 body fluid Anatomy 0.000 abstract description 10
- 230000006378 damage Effects 0.000 abstract description 10
- 208000014674 injury Diseases 0.000 abstract description 10
- 238000010791 quenching Methods 0.000 abstract description 10
- 206010010774 Constipation Diseases 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- 208000004880 Polyuria Diseases 0.000 abstract description 8
- 230000035619 diuresis Effects 0.000 abstract description 8
- 230000001717 pathogenic effect Effects 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000007774 longterm Effects 0.000 abstract description 3
- 239000003440 toxic substance Substances 0.000 abstract description 3
- 210000003254 palate Anatomy 0.000 abstract description 2
- 231100000167 toxic agent Toxicity 0.000 abstract description 2
- 230000006870 function Effects 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 8
- 238000011160 research Methods 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000002443 hepatoprotective effect Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- -1 3-oxo-oleanolic acid methyl ester Chemical class 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000628997 Flos Species 0.000 description 3
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000002633 protecting effect Effects 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- MQBFFYQCZCKSBX-UHFFFAOYSA-N 5-hydroxy-6,7,8-trimethoxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one Chemical compound COC1=C(OC)C(OC)=CC(C=2OC3=C(OC)C(OC)=C(OC)C(O)=C3C(=O)C=2)=C1 MQBFFYQCZCKSBX-UHFFFAOYSA-N 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000190633 Cordyceps Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 239000010282 Emodin Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- OBBJQZSMXOJMCN-UHFFFAOYSA-N Obtusin Natural products COc1cc2C=CC(=O)Oc2c3OCC(Oc13)C(=C)C OBBJQZSMXOJMCN-UHFFFAOYSA-N 0.000 description 2
- CFLNHFUPWNRWJA-UHFFFAOYSA-N Obtusin Chemical compound O=C1C2=CC(C)=C(O)C(OC)=C2C(=O)C2=C1C=C(OC)C(OC)=C2O CFLNHFUPWNRWJA-UHFFFAOYSA-N 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- RNXZPKOEJUFJON-UHFFFAOYSA-N aurantio-obtusin Chemical compound CC1=C(O)C(OC)=C2C(=O)C3=C(O)C(OC)=C(O)C=C3C(=O)C2=C1 RNXZPKOEJUFJON-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- IGGUPRCHHJZPBS-UHFFFAOYSA-N nonacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCC IGGUPRCHHJZPBS-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine Chemical compound C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- WEHXAEGTVPWKDY-UHFFFAOYSA-N toralactone Chemical compound C1=C(C)OC(=O)C=2C1=CC1=CC(OC)=CC(O)=C1C=2O WEHXAEGTVPWKDY-UHFFFAOYSA-N 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- OGJKMZVUJJYWKO-CYBMUJFWSA-N (+)-Stepharine Natural products C([C@H]1NCCC=2C=C(C(=C3C=21)OC)OC)C13C=CC(=O)C=C1 OGJKMZVUJJYWKO-CYBMUJFWSA-N 0.000 description 1
- KQSNKJUQYTZKHT-UHFFFAOYSA-N (-)-sinoacutine Natural products C1C2=CC=CC=C2C23CCC(=O)CC3C1NCC2 KQSNKJUQYTZKHT-UHFFFAOYSA-N 0.000 description 1
- CDDWAYFUFNQLRZ-KJVHGCRFSA-N (3beta,21beta,22beta)-olean-12-ene-3,21,22,24-tetrol Chemical compound C([C@@]12C)C[C@H](O)[C@](C)(CO)[C@@H]1CC[C@]1(C)[C@@H]2CC=C2[C@@H]3CC(C)(C)[C@@H](O)[C@@H](O)[C@]3(C)CC[C@]21C CDDWAYFUFNQLRZ-KJVHGCRFSA-N 0.000 description 1
- LJJHXRRUVASJDX-UHFFFAOYSA-N (S)-(E)-Lupinic acid Natural products OCC(C)=CCNC1=NC=NC2=C1N=CN2CC(N)C(O)=O LJJHXRRUVASJDX-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- GVTRUVGBZQJVTF-ORAYPTAESA-N 4090-18-0 Chemical compound C1C2=CC=C(OC)C(O)=C2[C@@]23C=C(OC)C(=O)C=C3[C@H]1N(C)CC2 GVTRUVGBZQJVTF-ORAYPTAESA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- CBOKHFLBNZMMAA-UHFFFAOYSA-N Emodin anthrone Natural products OC1=CC(O)=CC2=CC3=CC(C)=CC(O)=C3C(O)=C21 CBOKHFLBNZMMAA-UHFFFAOYSA-N 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229930188400 Gardenin Natural products 0.000 description 1
- XJMPAUZQVRGFRE-SCHFUKFYSA-N Gardenoside Natural products O=C(OC)C=1[C@H]2[C@H]([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)[C@@](O)(CO)C=C2 XJMPAUZQVRGFRE-SCHFUKFYSA-N 0.000 description 1
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 1
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 244000010000 Hovenia dulcis Species 0.000 description 1
- 235000008584 Hovenia dulcis Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CJJVPWAZSXVOOK-IGTKYRGASA-N Jujuboside B Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)CO2)O)[C@@H](O)CO[C@H]1O[C@@H]1C(C)(C)[C@H](CC[C@@]2(C)[C@@]34C[C@]5([C@H]([C@@](C[C@@H](O5)C=C)(C)O)[C@H]4CC[C@H]42)OC3)[C@]4(C)CC1 CJJVPWAZSXVOOK-IGTKYRGASA-N 0.000 description 1
- OAVAUZCEOWCYCC-BYHRGCEUSA-N Jujuboside B Natural products C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC[C@@H]6[C@H]7[C@](C)(O)C[C@@H](O[C@@]78C[C@@]56CO8)C=C(C)C)C3(C)C)OC[C@H](O)[C@@H]2O[C@@H]9O[C@H](CO)[C@@H](O)[C@H](O)[C@H]9O[C@@H]%10OC[C@@H](O)[C@H](O)[C@H]%10O)[C@H](O)[C@H](O)[C@H]1O OAVAUZCEOWCYCC-BYHRGCEUSA-N 0.000 description 1
- LJJHXRRUVASJDX-WWQRDVDESA-N L-lupinic acid Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2C[C@H]([NH3+])C([O-])=O LJJHXRRUVASJDX-WWQRDVDESA-N 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- RCQBVCISWCRYBO-SOYDKUNTSA-N Lupenone Natural products CC(=C)[C@@H]1CC[C@]2(C)CC[C@@H]3[C@H](CC[C@H]4[C@@]3(C)CC[C@H]5C(C)(C)C(=O)CC[C@]45C)[C@@H]12 RCQBVCISWCRYBO-SOYDKUNTSA-N 0.000 description 1
- GRBHNQFQFHLCHO-UHFFFAOYSA-N Lupenonq Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C GRBHNQFQFHLCHO-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- VLCHQFXSBHIBRV-KNNWKXJLSA-N Mussaenosidic acid Natural products O=C(O)C=1[C@@H]2[C@H]([C@H](O[C@@H]3[C@@H](O)[C@H](O)[C@H](O)[C@@H](CO)O3)OC=1)[C@](O)(C)CC2 VLCHQFXSBHIBRV-KNNWKXJLSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- GTRPODKMSBFDOI-UHFFFAOYSA-N Protopine Natural products CN1Cc2c3OCOc3ccc2C4C1Cc5cc6OCOc6cc5C4=O GTRPODKMSBFDOI-UHFFFAOYSA-N 0.000 description 1
- ZAALQOFZFANFTF-UHFFFAOYSA-N Pseudoprotipine Natural products C1=C2C(=O)CC3=CC=4OCOC=4C=C3CN(C)CCC2=CC2=C1OCO2 ZAALQOFZFANFTF-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 229930186706 Puerarin-xyloside Natural products 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- YSIFYNVXJOGADM-KDYWOABDSA-N Shanzhiside Chemical compound O([C@H]1[C@H]2[C@@H](C(=CO1)C(O)=O)[C@H](O)C[C@@]2(O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YSIFYNVXJOGADM-KDYWOABDSA-N 0.000 description 1
- PVPIPGMAEAJMTH-UHFFFAOYSA-N Shanzhiside Natural products OCC1OC(OC2OC=C(C3C(O)CC(O)C23)C(=O)O)C(O)C(O)C1O PVPIPGMAEAJMTH-UHFFFAOYSA-N 0.000 description 1
- NTFQHAKUNDRGJR-UHFFFAOYSA-N Sophoradiol Natural products CC1(C)CC(O)C2(C)CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1 NTFQHAKUNDRGJR-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- OAVAUZCEOWCYCC-NZTCAOINSA-N Zizyphussaponin III Natural products C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC[C@@H]6[C@H]7[C@](C)(O)C[C@@H](O[C@@]78C[C@@]56CO8)C=C(C)C)C3(C)C)OC[C@H](O)[C@@H]2O[C@@H]9O[C@H](CO)[C@@H](O)[C@H](O)[C@H]9O[C@@H]%10OC[C@@H](O)[C@H](O)[C@H]%10O)[C@H](O)[C@H](O)[C@@H]1O OAVAUZCEOWCYCC-NZTCAOINSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- OGJKMZVUJJYWKO-ZDUSSCGKSA-N ac1lh1t2 Chemical compound C([C@@H]1NCCC=2C=C(C(=C3C=21)OC)OC)C13C=CC(=O)C=C1 OGJKMZVUJJYWKO-ZDUSSCGKSA-N 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- CHWPMFMUQATVNK-ARYYTZDLSA-N dihydrosporogen AO-1 Natural products O[C@H]1[C@]2(C(C)=C)O[C@@H]2[C@]2(C)[C@@H](C)[C@H](O)CCC2=C1 CHWPMFMUQATVNK-ARYYTZDLSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- LAJSXCAVRQXZIO-UHFFFAOYSA-N emodin anthrone Chemical compound C1=C(O)C=C2CC3=CC(C)=CC(O)=C3C(=O)C2=C1O LAJSXCAVRQXZIO-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- MSCYPDAELCIJKB-UHFFFAOYSA-N fuseine Natural products O=C1Cc2cc3OCOc3c4c5ccccc5CC(N1)c24 MSCYPDAELCIJKB-UHFFFAOYSA-N 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- GRBHNQFQFHLCHO-BHMAJAPKSA-N lupenone Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C GRBHNQFQFHLCHO-BHMAJAPKSA-N 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- XJMPAUZQVRGFRE-AYDWLWLASA-N methyl (1s,4as,7s,7as)-7-hydroxy-7-(hydroxymethyl)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1h-cyclopenta[c]pyran-4-carboxylate Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1[C@](C=C2)(O)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJMPAUZQVRGFRE-AYDWLWLASA-N 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229930189775 mogroside Natural products 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- IUCHKMAZAWJNBJ-RCYXVVTDSA-N oleanolic acid 3-O-beta-D-glucosiduronic acid Chemical compound O([C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CCC(C[C@H]14)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O IUCHKMAZAWJNBJ-RCYXVVTDSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- OGJKMZVUJJYWKO-UHFFFAOYSA-N proaporphine Natural products C1=2C3=C(OC)C(OC)=CC=2CCNC1CC13C=CC(=O)C=C1 OGJKMZVUJJYWKO-UHFFFAOYSA-N 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- NAAXIGQVODQJOV-PXYOAQHISA-N puerarin xyloside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C(C1=C(C(C(C=2C=CC(O)=CC=2)=CO1)=O)C=C1)=C1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)CO1 NAAXIGQVODQJOV-PXYOAQHISA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- KLKFLNXANXGSIT-UHFFFAOYSA-N rubrofusarin Natural products O1C(C)=CC(=O)C2=C1C=C1C=C(O)C=C(OC)C1=C2O KLKFLNXANXGSIT-UHFFFAOYSA-N 0.000 description 1
- FPNKCZKRICBAKG-UHFFFAOYSA-N rubrofusarin Chemical compound O1C(C)=CC(=O)C=2C1=CC1=CC(OC)=CC(O)=C1C=2O FPNKCZKRICBAKG-UHFFFAOYSA-N 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- ZEGUWBQDYDXBNS-FVFJQADASA-N sophoradiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)[C@H](O)CC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C ZEGUWBQDYDXBNS-FVFJQADASA-N 0.000 description 1
- CDDWAYFUFNQLRZ-UHFFFAOYSA-N soyasapogenol A Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)C(O)C(O)C3(C)CCC21C CDDWAYFUFNQLRZ-UHFFFAOYSA-N 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种护肝解毒功能饮料及其制备方法,由小花青风藤30~50质量份,大枣10~20质量份,栀子5~10质量份,葛根10~15质量份,决明子10~15质量份,罗汉果10~15质量份配制后制备而成,为采用原料药直接煎制后配制而得到,或用煎制得到混合药粉后再配功能饮料。功能饮料中小花青风藤具有清热利湿、抗肝细胞损伤,护肝解毒作用,栀子、决明子有清热平肝、凉血解毒的作用,葛根、罗汉果有生津止渴,润肠通便的作用,大枣有补中益气,缓和药性的作用。充分利用各种原料药用功能,搭配合理,具有清热利湿,抗肝细胞损伤,护肝解毒,增强人体免疫力、解暑等作用。饮料清香爽口,口感较好,没有任何副作用,可长期饮用。
Description
技术领域
本发明涉及一种饮料,特别是涉及一种护肝解毒、抗肝细胞损伤功能饮料及其制备方法。
背景技术
随着时代的进步,人们学习、工作、生活节奏加快了,经常处在高度紧张状态,加上上下班路途长时间奔波、部分食物链激素的使用,消耗了体内大量的营养水分,从而引起内脏功能失调,感到失眠、乏力、无食欲、易疲劳、心悸、抵抗力差、记忆力减退、经常性感冒或口腔溃疡、便秘等不适症状,长久下去,身体健康受到影响,甚至导致疾病缠身。而肝脏是人体主要的代谢器官和最大的解毒器官,肝脏参与体内蛋白质、脂肪、糖类、维生素的代谢,可以将大部分内源性或外源性的有毒物质,通过氧化和结合的方式,转化为无毒或毒性较小的物质排出体外。只要人们肝脏功能正常,就不必忧虑体内毒素残留和中毒,因此我们要重视预防肝损伤,注意护肝解毒。
近年来,各种肝病及肝病前期患者呈现持续增长及年轻化的特点,药物不能长期用于护肝解毒,预防肝脏损伤,市场需求使用方便、价格低廉,具有很好保健作用的护肝产品,目前市场上销售的的各种具有保肝、护肝作用的饮料,涉及的大部分植物中药不是组方复杂,就是采用经济价值较高的中草药如虫草、人参等提取物作为原料,或者添加部分化学药物,存在生产成本过高和原料供应不稳定、产品口感差或疗效差等缺点。本发明饮料采用原料稳定纯天然植物配制,组方简单,口感较好,不添加任何化学药物,长期饮用,能降低人体血清谷丙转氨酶、谷草转氨酶,有效预防减少肝细胞损伤,达到护肝解毒、提高免疫力、防病健身等作用。
目前,关于中草药保肝。护肝饮料方面的相关专利文献报道也有不少。例如:1、申请号201110343483.1名称为“一种养肝护肝饮料及其制备方法”的发明专利,该专利是以水飞蓟、绞股蓝、维生素B2、B6、B12、维生素C、豆粕制备而成。2、申请号为CN101518353,名称为“一种解酒败火护肝饮料及制备方法”的发明专利,该专利是以葛根、葛花、枳椇子、金银花、菊花、生姜和葡萄糖制备而成。3、申请号为201010567627.7名称为“一种竹醋保健饮料及其制备方法”的发明专利,该专利是以人参、地黄、山药、红率、枸杞、茯苓、肉丛蓉、冬虫夏草、金樱子、蜂蜜制备而成。
发明内容
本发明要解决的目的是提供一种护肝解毒功能饮料及其制备方法。本发明功能饮料中小花青风藤具有清热利湿、抗肝细胞损伤,护肝解毒作用,栀子、决明子有清热平肝、凉血解毒的作用,葛根、罗汉果有生津止渴,润肠通便的作用,大枣有补中益气,缓和药性的作用。本发明功能饮料各种原料搭配合理,具有清热利湿,抗肝细胞损伤,护肝解毒,增强人体免疫力、解暑等作用。本发明饮料清香爽口,口感较好,没有任何副作用,可长期饮用。
本发明护肝解毒功能饮料采用的技术方案是:是由下述质量比例的原料药配制而成:
小花青风藤30~50质量份,大枣10~20质量份,栀子5~10质量份,葛根10~15质量份,决明子10~15质量份,罗汉果10~15质量份制备而成。
根据上述的护肝解毒功能饮料,所述护肝解毒功能饮料是由下述质量比例的原料药配制而成:
小花青风藤30质量份,大枣10质量份,栀子5质量份,葛根10质量份,决明子10质量份,罗汉果10质量份。
一种上述的护肝解毒功能饮料的制备方法,所述制备方法包括以下步骤:
a、按照上述任一种的配料比例配制各种原料,首先将配制的原料小花青风藤、大枣、栀子、葛根、决明子、罗汉果净制、干燥,小花青风藤、栀子、葛根、决明子在60℃的条件下炒制20min~40min,直至香味挥发出,通过粉碎至50~80目,放入锅内加水浸泡,水的加入量高出原料10cm~15cm,浸泡20min~40min,浸泡后进行加热,煮沸后保持50min~60min,按照同样的煎煮方法水煮两次,将两次所得液体混合、静置、过滤,过滤后药液静置;另将大枣、罗汉果放入锅内,加水浸泡,水的加入量高出原料10cm~15cm,浸泡30min,浸泡后进行加热,煮沸后保持20min~30min,静置、过滤,然后合并上述2种液体,浓缩、干燥,粉碎过100目,得到混合药粉。
b、将纯净水加热至80—90℃,把步骤a得到的混合药粉加入溶解,搅拌混合均匀后,得到功能液体饮料;
c、灌装封口,将步骤b所得功能液体饮料进行灌装,灌装时温度保持70℃~80℃,灌装后及时封口;
d、杀菌冷却,将步骤c灌装后的饮料采用蒸汽进行杀菌,进行杀菌时的杀菌温度为121℃,杀菌时间为15min~20min,杀菌后冷却至室温,得到本发明产品瓶装护肝解毒功能饮料;
一种上述的护肝解毒功能饮料的制备方法,所述制备方法包括以下步骤:
a、按照上述任一项所述的配料比例配制各种原料,将配制的原料小花青风藤、大枣、栀子、葛根、决明子、罗汉果净制、干燥,小花青风藤、栀子、葛根、决明子在60℃的条件下炒制20min~40min,直至香味渗出,通过粉碎至50目~80目,放入锅内加水浸泡,水的加入量高出原料10cm~15cm,浸泡20min~40min,浸泡后进行加热,煮沸后保持50min~60min,按照同样的煎煮方法水煮两次,将两次所得液体混合、静置、过滤,过滤后得到混合药液;
将清洗干净的大枣放入浸泡容器内,并加入大枣质量的4~6倍的水浸泡30min,进行加热,煮沸后保持20min~30min,静置、过滤,过滤后得到大枣汁液;
将清洗干净的罗汉果放入浸泡容器内,并加入罗汉果质量的4~6倍的水浸泡30min,进行加热,煮沸后保持20min~30min,静置、过滤,过滤后得到罗汉果汁液;
b、将步骤a得到的混合药液、大枣汁液、罗汉果汁液进行混合,混合均匀,将其进行浓缩,得到浓缩混合药液;
c、将纯净水加热至80℃—90℃,把步骤b得到的浓缩混合药液加入溶解,搅拌混合均匀后,得到功能液体饮料;
d、灌装封口:将步骤c所得功能液体饮料进行灌装,灌装时液体饮料的温度保持70℃~80°C,灌装后及时封口;
e、杀菌冷却:将步骤d灌装后的饮料采用蒸汽进行杀菌,进行杀菌时的杀菌温度为121°C,杀菌时间为15min~20min。
本发明护肝解毒功能饮料主要成分的功效作用:
小花青风藤:味苦、甘,性寒。功能主治:具有清热利湿、抗肝细胞损伤、护肝解毒、止血等功效。常用于治疗黄疸热证、外伤出血、病毒性肝炎等症【1—3】。
研究发现小花青风藤含齐墩果酸、羽扇豆酸、3a-羟基-齐墩果酸甲酯、阿江三萜酸、3-氧代-齐墩果酸甲酯、2β,3β,19a-羟基-三-乌苏-12-烯-28酸、古柯三萜二醇、反-山楂酸【4】、(—)—青风藤碱A、5-氧阿朴菲碱、β-黑瑞亭、原鸦片碱【5】、槲皮素等成分【6】;具有抗肝细胞损伤,保护肝脏作用。
大枣:味甘、温,入肺、脾经。功能主治:具有补脾和胃,益气生津,调营卫,解药毒等功效。常用于治疗治胃虚食少,脾弱便溏,气血津液不足,营卫不和,心悸怔忡、急慢性肝炎等症【7】。
研究发现大枣含大枣皂甙Ⅰ、Ⅱ、Ⅲ、酸枣仁皂甙B、光千金藤碱、葡萄糖、果糖、蔗糖、环磷腺苷、环磷乌苷等。具有增强肌力、消除疲劳、扩张血管、增加心肌收缩力、改善心肌营养、降低血清谷丙转氨酶水平等作用【8】。
栀子:味苦性寒,入心、肺、三焦经。功能主治:具有清热,泻火,凉血等功效。常用于治疗热病虚烦不眠,黄疸,淋病,消渴,目赤,咽痛,吐血,衄血,血痢,尿血,热毒疮疡,扭伤肿痛等症【9】。
研究发现栀子含黄酮类栀子素、果胶、鞣质、藏红花素、藏红花酸、D-甘露醇、廿九烷、β-谷甾醇,栀子甙、去羟栀子甙泊素-1-葡萄糖甙,格尼泊素-1-β-D-龙胆二糖甙、山栀甙等成分,有护肝利胆、降压、镇静作用【10】。
葛根:味甘、辛,入肺、胃、脾。功能主治:具有升阳解肌,透疹止泻,生津止渴等功效。常用于治疗伤寒、温热头痛项强,烦热消渴,脾虚泄泻,癍疹不透,高血压,心绞痛,耳聋等症【11】。
研究发现葛根含大豆甙元,大豆甙,葛根素,大豆甙元-葡萄糖甙,染料木素,染料木素-芹菜糖基-葡萄糖甙,葛根素木糖甙,葛根酚,葛根甙,刺芒柄花素-7-葡萄糖甙,羽扇烯酮,β-谷甾醇,尿囊素,β-谷甾醇-β-D-葡萄糖甙,6,7-二甲氧基香豆精,槐花二醇,大豆皂醇A、B,葛根皂醇为甙元的三萜皂甙、异黄酮等成分,具有解热、消炎、扩张心冠脉、增加脑血流量、缓解肌肉痉挛等作用【12】。
决明子:味甘、苦、咸、微寒,入肝、大肠经。功能主治:具有清热平肝、降脂降压、润肠通便、明目等功效。常用于治疗风热赤眼,青盲,高血压,肝炎,肝硬化腹水,习惯性便秘等症【13】。
研究发现决明子含大黄酚、大黄素、芦荟大黄素、大黄酸、大黄素葡萄糖甙、大黄素蒽酮、大黄素甲醚、决明素、钝叶决明素、橙黄决明素,新月孢子菌玫瑰色素、决明松、决明内酯、维生素A及微量元素铁、锌、锰、铜、镍、钴、钼等成分,具有平喘、保肝、降压、降低胆固醇、强心作用【14】。
罗汉果味甘、凉,无毒;入肺、脾经。功能主治:具有润肺止咳,生津止渴,润肠通便等功效。常用于治疗用于肺火燥咳,咽痛失音,咳嗽不爽、肠燥便秘等症【15】。
研究发现罗汉果含罗汉果甙,果糖、氨基酸、黄酮及微量元素及特殊的抗氧化物质成分,具有能化解体内新陈代谢后产生的游离基,防止游离基氧化身体组织,保持身体机能正常运作的作用【16】。
本发明功能饮料中小花青风藤具有清热利湿、抗肝细胞损伤、护肝解毒等功效,为主要原料;栀子具有清热泻火,护肝利胆之功效,葛根具有升阳解肌,生津止渴之功效,大枣有补中益气,补五脏,缓和药性之功能,罗汉果有润肺止咳,生津止渴之功效,决明子具有清热平肝,润肠通便之功效,并且大枣、罗汉果能调味、增加口感作用。上述原料搭配合理,属纯天然植物配伍,不添加任何防腐剂,无副作用,无不良反应。
护肝解毒功能饮料试用的实际功效:经过本功能饮料的毒性、和致残、致畸研究,确定饮料成分无毒副作用,我们才开始进行本项实际功效测定。
为证明一种护肝解毒功能饮料的实际功效,我们按规定招聘选定了志愿人员6人,经医院肝脏超声检查患有轻度脂肪肝3人,肝功能检查转氨酶高于40U/L5人,年龄在35—52岁之间,进行试验,实验地点为贵州省兴义市,试验服用本饮料500毫升/天,实验以观察法进行,时间2—6个月,实验结果显示护肝解毒功能饮料,其效果是对肝脏具有显著而有效的保护作用。见附表一
附表一
自愿者服用护肝解毒功能饮料前后情况
本发明护肝解毒功能饮料有益效果:
1、本发明护肝解毒功能饮料所需原料药种类较少,配伍简单明了,成本低。本发明原料中苗药小花青风藤具有清热利湿、利胆、抗肝细胞损伤保肝作用;大枣有补中益气,缓和药性作用;罗汉果有润肺止咳,生津止渴作用;栀子具有清热泻火,护肝利胆作用;葛根具有升阳解肌,生津止渴作用;决明子:具有清热平肝、降脂降压、润肠通便作用。本发明功能饮料各种原料搭配合理,具有清热利湿、护肝解毒、保护肝脏、健脾益胃、清肺润肠、增强人体免疫力等作用。本发明饮料清爽可口,口感较好,没有不良副作用。
2、本发明是以小花青风藤,、大枣、栀子、葛根、决明子、罗汉果为原料制备而成的具有护肝解毒功效的功能饮料。本发明通过原料中各种营养物质的有机结合,有效地将多种不同成分融入在产品中,通过这些成分相互协同作用,达到护肝解毒、生津止渴、凉血养阴的功效。同时又增强人体免疫力,提高抗病能力,预防疾病,增强健康。
3、本发明产品作为饮料,不仅能够起到解渴作用,而且还有保健功能,在喝饮料的同时解决肝功能异常的恢复功能,喝后使人感到清爽怡人,能起到有病治病无病健身的效果,对人体无任何毒副作用。
具体实施方式:
实施例1:
本发明护肝解毒功能饮料是由下述质量比例的原料药配制而成:
小花青风藤30质量份,大枣10质量份,栀子5质量份,葛根10质量份,决明子10质量份,罗汉果10质量份。
本发明上述护肝解毒功能饮料的制备方法,所述制备方法的详细步骤如下:
按照上述护肝解毒功能饮料的配料比例配制各种原料,将配制的原料小花青风藤、大枣、栀子、葛根、决明子、罗汉果净制、干燥,小花青风藤、栀子、葛根、决明子在60℃的条件下炒制20~40min,直至香味挥发出,通过粉碎至50目~80目,放入锅内加水浸泡,水的加入量高出原料10cm~15cm,浸泡20min~40min,浸泡后进行加热,煮沸后保持50min~60min,按照同样的煎煮方法水煮两次,将两次所得液体混合、静置、过滤,过滤后药液静置;将大枣、罗汉果放入锅内,加水浸泡,水的加入量高出原料10min~15cm,浸泡30min,浸泡后进行加热,煮沸后保持20~30min,静置、过滤,然后合并上述2种液体,浓缩、干燥,粉碎过100目,得到混合药粉。
b、将纯净水加热至80—90℃,把步骤a得到的混合药粉加入溶解,搅拌混合均匀后,得到功能液体饮料。
c、灌装封口,将步骤b所得功能液体饮料进行灌装,灌装时温度保持70~80°C,灌装后及时封口。
d、杀菌冷却,将步骤c灌装后的饮料采用蒸汽进行杀菌,进行杀菌时的杀菌温度为121°C,杀菌时间为15~20min,杀菌后冷却至室温,得到本发明产品瓶装护肝解毒功能饮料。
实施例2:与实例1基本相同,不同之处在于:
本发明护肝解毒功能饮料是由下述质量比例的原料药配制而成:
小花青风藤50质量份,大枣10质量份,栀子5质量份,葛根10质量份,决明子10质量份,罗汉果10质量份。
a、按照上述护肝解毒功能饮料的配料比例配制各种原料,将配制的原料小花青风藤、大枣、栀子、葛根、决明子、罗汉果净制、干燥,小花青风藤、栀子、葛根、决明子在60℃的条件下炒制20min~40min,直至香味渗出,通过粉碎至50目~80目,放入锅内加水浸泡,水的加入量高出原料10cm~15cm,浸泡20min~40min,浸泡后进行加热,煮沸后保持50min~60min,按照同样的煎煮方法水煮两次,将两次所得液体混合、静置、过滤,过滤后得到混合药液;
将清洗干净的大枣放入浸泡容器内,并加入大枣质量5倍的水浸泡30min,进行加热,煮沸后保持20min~30min,静置、过滤,过滤后得到大枣汁液;
将清洗干净的罗汉果放入浸泡容器内,并加入罗汉果质量5倍的水浸泡30min,进行加热,煮沸后保持20min~30min,静置、过滤,过滤后得到罗汉果汁液;
b、将步骤a得到的混合药液、大枣汁液、罗汉果汁液进行混合,混合均匀,将其进行浓缩,得到浓缩混合药液;
c、将纯净水加热至80℃—90℃,把步骤b得到的浓缩混合药液加入溶解,搅拌混合均匀后,得到功能液体饮料;
d、灌装封口:将步骤c所得功能液体饮料进行灌装,灌装时液体饮料的温度保持70℃~80℃,灌装后及时封口;
e、杀菌冷却:将步骤d灌装后的饮料采用蒸汽进行杀菌,进行杀菌时的杀菌温度为121℃,杀菌时间为15~20min,杀菌后冷却至室温,得到本发明产品瓶装护肝解毒功能饮料。
实施例3:与实施例1基本相同,不同之处在于:
本发明护肝解毒功能饮料是由下述质量比例的原料药配制而成:
小花青风藤45质量份,大枣10质量份,栀子5质量份,葛根10质量份,决明子10质量份,罗汉果10质量份。
本发明上述护肝解毒功能饮料的制备方法与实施例1相同
实施例4:与实施例1基本相同,不同之处在于:
本发明护肝解毒功能饮料是由下述质量比例的原料药配制而成:
小花青风藤40质量份,大枣10质量份,栀子5质量份,葛根10质量份,决明子10质量份,罗汉果10质量份。
本发明上述护肝解毒功能饮料的制备方法与实施例1相同
实施例5:与实施例1基本相同,不同之处在于:
本发明护肝解毒功能饮料是由下述质量比例的原料药配制而成:
小花青风藤35质量份,大枣10质量份,栀子5质量份,葛根10质量份,决明子10质量份,罗汉果10质量份。
本发明上述护肝解毒功能饮料的制备方法与实施例2相同。
实施例6:与实施例1基本相同,不同之处在于:
本发明护肝解毒功能饮料是由下述质量比例的原料药配制而成:
小花青风藤30质量份,大枣15质量份,栀子5质量份,葛根10质量份,决明子15质量份,罗汉果10质量份。
本发明上述护肝解毒功能饮料的制备方法与实施例1相同
实施例7:与实施例1基本相同,不同之处在于:
本发明护肝解毒功能饮料是由下述质量比例的原料药配制而成:
小花青风藤小花青风藤30质量份,大枣10质量份,栀子5质量份,葛根15质量份,决明子10质量份,罗汉果10质量份。
本发明上述护肝解毒功能饮料的制备方法与实施例2相同
实施例8:与实施例1基本相同,不同之处在于:
本发明护肝解毒功能饮料是由下述质量比例的原料药配制而成:
小花青风藤30质量份,大枣20质量份,栀子10质量份,葛根10质量份,决明子10质量份,罗汉果10质量份。
本发明上述护肝解毒功能饮料的制备方法与实施例1相同
实施例9:与实施例1基本相同,不同之处在于:
本发明护肝解毒功能饮料是由下述质量比例的原料药配制而成:
小花青风藤30质量份,大枣10质量份,栀子10质量份,葛根15质量份,决明子10质量份,罗汉果10质量份。
本发明上述护肝解毒功能饮料的制备方法与实施例1相同
实施例10:与实施例1基本相同,不同之处在于:
本发明护肝解毒功能饮料是由下述质量比例的原料药配制而成:
小花青风藤30质量份,大枣15质量份,栀子5质量份,葛根15质量份,决明子15质量份,罗汉果15质量份。
本发明上述护肝解毒功能饮料的制备方法与实施例1相同。
本发明上述护肝解毒功能饮料的制备方法看似两种方法,其成分是一致的,而先抽取本发明上述护肝解毒功能饮料的浓缩粉料,适宜到原料药产地生产出功能饮料的浓缩粉料后,异地进行加工生产,节约运输加工成本。
资料来源
(1)刘易蓉,邱晓春,陈惠.小花清风藤保肝作用实验研究中国药房,2008,19.(30)2340-2342
(2)胡柞俊、邱少文等小花清风治疗病毒性肝炎84例临床总结贵州医药,1989,13.(17)47-48
(3)赵洁,姚默等清风藤属药学研究新进展安徽农业科学2011,39(32)19804-19805
(4)邓赟,陈谨等小花清风藤生物碱成分研究天然产物研究与开发2003,15(4)19804-19805
(5)陈谨,邓赟等小花清风藤三萜成分的研究中草药2004,35(17)16-17
(6)刘易蓉,梁光仪等小花清风藤中槲皮素的提取工艺研究贵州医药2006,130(6)566-567
(7)百度收索药品通大枣的功效与作用【功能主治】【临床应用】39健康网药品通药品查询数据库提供
(8)百度收索药品通大枣的功效与作用【成份】39健康网药品通药品查询数据库提供
(9)百度收索药品通栀子的功效与作用【功能主治】【临床应用】39健康网药品通药品查询数据库提供
(10)百度收索药品通栀子的功效与作用【成份】39健康网药品通药品查询数据库提供
(11)百度收索药品通葛根的功效与作用【功能主治】【临床应用】39健康网药品通药品查询数据库提供
(12)百度收索药品通葛根的功效与作用【成份】39健康网药品通药品查询数据库提供
(13)百度收索药品通决明子功效与作用【功能主治】【临床应用】39健康网药品通药品查询数据库提供
(14)百度收索药品通决明子的功效与作用【成份】39健康网药品通药品查询数据库提供
(15)百度收索药品通罗汉果功效与作用【功能主治】【临床应用】39健康网药品通药品查询数据库提供
(16)百度收索药品罗汉果的功效与作用【成份】39健康网药品通药品查询数据库提供。
Claims (4)
1.一种护肝解毒功能饮料,其特征在于是由下述质量比例的原料药配制而成:小花青风藤30~50质量份,大枣10~20质量份,栀子5~10质量份,葛根10~15质量份,决明子10~15质量份,罗汉果10~15质量份。
2.根据权利要求1所述的一种护肝解毒功能饮料,其特征在于是由下述质量比例的原料药配制而成:小花青风藤30质量份,大枣10质量份,栀子5质量份,葛根10质量份,决明子10质量份,罗汉果10质量份。
3.权利要求1所述的一种护肝解毒功能饮料的制备方法,其特征在于,所述制备方法包括以下步骤
a、按照权利要求1所述的任一组配料比例配制好原料药,小花青风藤、大枣、栀子、葛根、决明子、罗汉果分别净制,将小花青风藤、栀子、葛根、决明子在60℃的条件下炒制20min~40min,直至药味挥发出,粉碎过50~80目,放入锅内加水浸泡,水的加入量高出原料10cm~15cm,浸泡20min~40min,浸泡后进行加热,煮沸后保持50min~60min,按照同样的煎煮方法用水煮两次,将两次所得液体混合、静置、过滤,过滤后药液静置;将大枣、罗汉果放入锅内,加水浸泡,水的加入量高出原料10cm~15cm,浸泡30min,浸泡后进行加热,煮沸后保持20min~30min,静置、过滤,然后合并上述2种液体,混合均匀后,浓缩、干燥,粉碎过100目,得到混合药粉;
b、将纯净水加热至80℃~90℃,把步骤a得到的混合药粉加入溶解,搅拌混合均匀后,得到功能液体饮料;
c、灌装封口,将步骤b所得功能液体饮料进行灌装,灌装时液体饮料的温度保持70℃~80℃,灌装后及时封口;
d、杀菌冷却,将步骤c灌装后的饮料采用蒸汽进行杀菌,进行杀菌时的杀菌温度为121℃,杀菌时间为15min~20min,杀菌后冷却至室温,得到产品瓶装护肝解毒功能饮料。
4.根据权利要求1所述的一种护肝解毒功能饮料的制备方法,其特征在于所述制备方法包括以下步骤:
a、按照权利要求1所述的任一组配料比例配制好原料药,将小花青风藤、大枣、栀子、葛根、决明子、罗汉果净制,小花青风藤、栀子、葛根、决明子在60℃的条件下炒制20min~40min,直至药味挥发出,粉碎过50目~80目,放入锅内加水浸泡,水的加入量高出原料10cm~15cm,浸泡20min~40min,浸泡后进行加热,煮沸后保50min~60min,按照同样的煎煮方法水煮两次,将两次所得液体混合、静置、过滤,过滤后得到混合药液;将清洗干净的大枣放入浸泡容器内,并加入水,水的加入量为大枣质量的4~6倍,浸泡30min,进行加热,煮沸后保持20min~30min,静置、过滤,过滤后得到大枣汁液;将清洗干净的罗汉果放入浸泡容器内,并加入水,水的加入量为罗汉果质量的4~6倍,浸泡30min,进行加热,煮沸后保持20min~30min,静置、过滤,过滤后得到罗汉果汁液;
b、将步骤a得到的混合药液、大枣汁液、罗汉果汁液进行混合,混合均匀,加热、浓缩,得到浓缩混合药液;
c、将纯净水加热至80℃~90℃,把步骤a得到的浓缩混合药液加入溶解,搅拌混合均匀后,得到功能液体饮料;
d、灌装封口:将步骤c所得功能液体饮料进行灌装,灌装时液体饮料的温度保持70℃~80℃,灌装后及时封口;
e、杀菌冷却:将步骤d灌装后的饮料采用蒸汽进行杀菌,进行杀菌时的杀菌温度为121℃,杀菌时间为15min~20min,杀菌后冷却至室温,得到产品瓶装护肝解毒功能饮料。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410314999.7A CN104041907B (zh) | 2014-07-04 | 2014-07-04 | 一种护肝解毒功能饮料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410314999.7A CN104041907B (zh) | 2014-07-04 | 2014-07-04 | 一种护肝解毒功能饮料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104041907A CN104041907A (zh) | 2014-09-17 |
CN104041907B true CN104041907B (zh) | 2016-06-29 |
Family
ID=51495774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410314999.7A Expired - Fee Related CN104041907B (zh) | 2014-07-04 | 2014-07-04 | 一种护肝解毒功能饮料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104041907B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104522244A (zh) * | 2014-12-26 | 2015-04-22 | 邓小健 | 无糖罗汉果饮料及其生产方法 |
CN106551227A (zh) * | 2016-11-25 | 2017-04-05 | 南昌理工学院 | 一种红军菜活性功能饮料的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1418661A (zh) * | 2002-12-06 | 2003-05-21 | 何宗祥 | 治疗肝炎的中药制剂 |
CN1586546A (zh) * | 2004-07-15 | 2005-03-02 | 贵州省兴义市吉仁堂药业公司 | 一种治疗肝胆疾病的药物及其制备方法 |
-
2014
- 2014-07-04 CN CN201410314999.7A patent/CN104041907B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1418661A (zh) * | 2002-12-06 | 2003-05-21 | 何宗祥 | 治疗肝炎的中药制剂 |
CN1586546A (zh) * | 2004-07-15 | 2005-03-02 | 贵州省兴义市吉仁堂药业公司 | 一种治疗肝胆疾病的药物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
罗汉果保肝活性部位的研究;王勤等;《中药药理与临床》;19981231;第14卷(第6期);第31-32页 * |
罗汉果甜苷保肝作用实验研究;肖刚等;《中国实验方剂学杂志》;20130131;第19卷(第2期);第196-200页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104041907A (zh) | 2014-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104041644B (zh) | 润肠茶及其制备方法 | |
CN103725573B (zh) | 一种龙桂酒及其制备方法 | |
CN101982082B (zh) | 一种养心草复合保健茶 | |
CN104840807A (zh) | 一种清肺解毒抗霾饮品及其制备方法 | |
CN104115959A (zh) | 一种保健茶饮料 | |
CN105454576A (zh) | 茉莉花八宝茶及其制备方法 | |
CN106035860A (zh) | 一种减肥降压养生袋装茶及其制备方法 | |
CN102228275B (zh) | 一种含荸荠的中药植物饮料及其制备方法 | |
CN104041907B (zh) | 一种护肝解毒功能饮料及其制备方法 | |
CN104873826A (zh) | 一种可清肺祛湿的茶饮及其制备方法 | |
CN106377599A (zh) | 一种金莲花口香糖及其制备方法 | |
CN102960505A (zh) | 一种清咽利喉茶及其制备方法 | |
CN104115960A (zh) | 一种鲜芦根凉茶饮料 | |
CN106173714A (zh) | 一种护肝养胃的饮料及其制备方法 | |
CN104232434A (zh) | 一种能够缓解便秘、高血压、高血脂、肥胖作用的山楂酒 | |
CN105558159A (zh) | 一种六堡茶醋饮料及其制备方法 | |
CN106418540A (zh) | 一种护肝解毒功能饮料及其制备方法 | |
CN104397236A (zh) | 平胃养生中药茶饮品及制备方法 | |
CN113519737A (zh) | 一种解酒护肝的多肽饮品及其制备方法 | |
CN105327261A (zh) | 一种莱菔子养胃中药组合物及其制备方法 | |
CN104069399A (zh) | 消除消化不良型口臭的中药汤剂及制备方法 | |
CN104479952A (zh) | 一种山黄皮果甜酒酿及其制备方法 | |
CN104383209A (zh) | 补脾和胃酒及制备方法 | |
CN103055292A (zh) | 一种温胆药物组合物及其制备方法 | |
CN104958531B (zh) | 一种治疗偏头痛的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160629 Termination date: 20170704 |
|
CF01 | Termination of patent right due to non-payment of annual fee |